Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of California, Irvine
RenJi Hospital
The Netherlands Cancer Institute
Queen Mary University of London
British Columbia Cancer Agency
University of California, Irvine
Sheba Medical Center